CHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Published on
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Published on
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Published on
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.
Published on
Born with sickle cell disease, Naomi receives breakthrough treatments and screenings at CHOP to keep her symptoms in check and protect her from strokes.
Published on
Researchers have found a key protein that could become a target for a new treatment for sickle cell disease. In lab tests, blocking the protein reduces sickling that distorts red blood cells.
Published on
Proceeds support sickle cell research and patient care at Children’s Hospital of Philadelphia.
Published on
CHOP scientists altered red blood cells to produce a form of hemoglobin not affected by the mutation that causes sickle cell disease. The findings may lead to a new therapy for the disease.